ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

February 19, 2010

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

NIH Revises K Series Awards; RFP Available; Program Announcement

June 9, 1995

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992